Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers.
Presently, the Caco-2 cell culture model is widely used during drug discovery and development as a predictive tool for the oral absorption of drug candidates. For transport experiments in the Caco-2 system, HBSS-like buffered salt solutions are commonly used, although different shortcomings have been associated with the use of these buffers. In this paper, we investigated the effect of using fasted state simulated intestinal fluid (FaSSIF) as potential biorelevant medium for the drug permeability estimation across Caco-2 monolayers. The transport characteristics of 19 model compounds were determined in the Caco-2 cell culture model in the presence of FaSSIF as compared to classic transport medium. A sigmoidal relation was obtained when the estimated P(app), s of the apical to basolateral transport were plotted versus the reported values of the fraction absorbed in man. Although no effect of FaSSIF as compared to classic transport medium (TM) was observed on the total predictability of the model, an impact was demonstrated (1) on the bi-directional transport of actively transported drugs (including talinolol, digoxin and doxorubicin), (2) on recovery and (3) on the solubility and permeability estimation of poorly water-soluble drugs. The observed differences may be attributed to a P-gp inhibitory effect of sodium taurocholate (NaTC), micellar encapsulation by the NaTC/lecithin mixed micelles and/or an increase of the solubility of lipophilic drugs. As the experimental conditions should mimic the physiological in vivo conditions, the use of FaSSIF as medium during Caco-2 experiments may improve the biorelevance of the model.
Ingels
F
F
Biopharmaceutics & Drug Delivery, Lilly Development Centre, 11 rue Granbonpré, 1348 Mont-Saint-Guibert, Belgium.
Beck
B
B
Oth
M
M
Augustijns
P
P
D001692:Biological Transport / Q000502:physiology; D018938:Caco-2 Cells; D003613:Danazol / Q000493:pharmacokinetics; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects / Q000502:physiology*; D007419:Intestinal Secretions / Q000737:chemistry* / Q000378:metabolism; D008823:Micelles; D008954:Models, Biological; D010539:Permeability / Q000187:drug effects; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D013656:Taurocholic Acid / Q000378:metabolism
D008823:Micelles; D004364:Pharmaceutical Preparations; D013656:Taurocholic Acid; D003613:Danazol